Cephalexin Tablet, Film Coated
Product Images NDC 59651-784

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cephalexin (NDC 59651-784). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Cephalexin Fig1)

This text provides information on a film-coated tablet containing Cephalexin monohydrate, which is equivalent to 250 mg. It includes details such as the distributor (Aurobindo Pharma USA, Inc.), dosage instructions for adults, recommendations for parenteral cephalosporin therapy, storage conditions, and a manufacturing location (India). Additionally, there is a note about keeping the medication out of reach of children and the information that will be printed on the packaging during packing.*

FDA Label Image

Fig2 (Cephalexin Fig2)

The text provides information about Cephalexin tablets containing 500 mg of Cephalexin monohydrate, distributed by Aurabindo Pharma USA, Inc. Instructions for the usual adult dosage, storage conditions, and manufacturing details are also included. It is important to keep the tablets in a tightly closed, light-resistant container and out of reach of children. The tablets should be stored at temperatures between 15°C to 30°C. Additionally, details about the manufacturer's address and a code for identification purposes are provided.*

FDA Label Image

Str (Cephalexin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.